What are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular-therapies, in the UK?

Abstract excerpt

<h4>Introduction</h4> Haematological cancers are common in the UK, with a variety of morphologies. Stem cell transplants and chimeric antigen receptor (CAR) T-cell therapies provide significant options for hard to treat haematological cancers, although with difficult to predict outcomes. Research into the determinates of treatment efficacy, and access to treatments, is key to ensuring equal benefit across patients...

Topics

Open a Topic to create a Post that cites this publication.

• Acute Lymphoblastic Leukemia research
• Attitude to Health
• BRCA gene mutations in cancer
• Cancer Genomics and Diagnostics
• Ethics in Clinical Research
• Hematopoietic Stem Cell Transplantation
• Molecular Biology Techniques and Applications
• Renal Transplantation Outcomes and Treatments

Identifiers and source

Literature Corpus work

70a03ca8-5f14-5f1e-a4af-07682e50ba91

DOI

10.1101/2024.11.18.24317089